Jonathan W. Kotula, PhD, is an expert in synthetic biology and host-microbial interactions, with over 15 years of research and development experience. He is the head of science at Felix Biotechnology, Inc. He has led interdisciplinary teams of researchers to develop tools for bacterial genome editing for therapeutic purposes, has initiated research programs at biotechnology companies including Synlogic, Inc., and Caribou Biosciences, Inc., and is an inventor on several bacterial engineering patents. He has been invited to speak about his research at universities, museums, conferences, and radio shows. He holds a BS from Pennsylvania State Univ. in biochemistry and molecular biology and a PhD from Duke Univ. in molecular genetics and microbiology, and he has conducted postdoctoral research in synthetic biology at Harvard Medical School and the Wyss Institute.